- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy and Chemoprevention by Thiazolidinediones
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2015-03-20
DOI
10.1155/2015/845340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non–Small Cell Lung Cancer
- (2015) Raju C. Reddy et al. NEOPLASIA
- Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
- (2013) Matteo Monami et al. ACTA DIABETOLOGICA
- The PPARγ Agonist Efatutazone Increases the Spectrum of Well-Differentiated Mammary Cancer Subtypes Initiated by Loss of Full-Length BRCA1 in Association with TP53 Haploinsufficiency
- (2013) Rebecca E. Nakles et al. AMERICAN JOURNAL OF PATHOLOGY
- Rivoglitazone: A New Thiazolidinedione for the Treatment of Type 2 Diabetes Mellitus
- (2013) Robin L Koffarnus et al. ANNALS OF PHARMACOTHERAPY
- The PPARγ agonist pioglitazone crosses the blood–brain barrier and reduces tumor growth in a human xenograft model
- (2013) Christian Grommes et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- An update on molecular biology of thyroid cancers
- (2013) Ozgur Omur et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer
- (2013) Scott J Diede et al. Epigenetics
- Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis
- (2013) Temjenmongla Imchen et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Combined Treatment With Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Ligands and Gamma Radiation Induces Apoptosis by PPARγ-Independent Up-Regulation of Reactive Oxygen Species-Induced Deoxyribonucleic Acid Damage Signals in Non-Small Cell Lung Cancer Cells
- (2013) Eun Jong Han et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Differentiated Thyroid Cancer: A New Perspective with Radiolabeled Somatostatin Analogues for Imaging and Treatment of Patients
- (2013) Annibale Versari et al. THYROID
- Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro
- (2013) Ying Liu et al. TUMOR BIOLOGY
- Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells
- (2012) Tamotsu Tsukahara et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice
- (2012) B Shen et al. BRITISH JOURNAL OF CANCER
- PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells
- (2012) E Pestereva et al. BRITISH JOURNAL OF CANCER
- A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies
- (2012) Michael J. Pishvaian et al. CANCER
- Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development in Mice
- (2012) M. -Y. Li et al. CURRENT CANCER DRUG TARGETS
- Pioglitazone therapy in progressive differentiated thyroid carcinoma
- (2012) A. Bockisch et al. NUKLEARMEDIZIN-NUCLEAR MEDICINE
- Macrophage polarization: The answer to the diet/inflammation conundrum?
- (2012) M. Dall’Asta et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy
- (2012) I Jagan et al. ONCOGENE
- Impact of Enhanced Detection on the Increase in Thyroid Cancer Incidence in the United States: Review of Incidence Trends by Socioeconomic Status Within the Surveillance, Epidemiology, and End Results Registry, 1980–2008
- (2012) Nan Li et al. THYROID
- Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARγ-dependent and PPARγ-independent pathways
- (2011) Besstina E. Lyles et al. CELL CYCLE
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
- (2011) A. Ferrara et al. DIABETES CARE
- Pioglitazone Induces a Proadipogenic Antitumor Response in Mice with PAX8-PPARγ Fusion Protein Thyroid Carcinoma
- (2011) Melissa E. Dobson et al. ENDOCRINOLOGY
- PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells
- (2011) Hironori Koga INTERNATIONAL JOURNAL OF ONCOLOGY
- Synergistic Interactions between Heregulin and Peroxisome Proliferator-activated Receptor-γ (PPARγ) Agonist in Breast Cancer Cells
- (2011) Bae-Hang Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers
- (2011) Yoshihito Yokoyama et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Peroxisome Proliferator-Activated Receptors Modulate Proliferation and Angiogenesis in Human Endometrial Carcinoma
- (2011) M. Nickkho-Amiry et al. MOLECULAR CANCER RESEARCH
- Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice
- (2011) Huijing Fu et al. MOLECULAR CARCINOGENESIS
- Activation of PPARγ in Myeloid Cells Promotes Lung Cancer Progression and Metastasis
- (2011) Howard Li et al. PLoS One
- Experiencia con rosiglitazona como tratamiento rediferenciador en un caso de carcinoma papilar de tiroides con metástasis pulmonares y ausencia de captación de radioyodo
- (2011) M. Elola et al. Revista Espanola de Medicina Nuclear
- Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroids
- (2010) Eva Gottfried et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells
- (2010) Jorge Humberto Tapia-Pérez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth
- (2010) Naohiko Hamaguchi et al. CANCER SCIENCE
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity
- (2010) Alberto Mantovani et al. CURRENT OPINION IN IMMUNOLOGY
- Pioglitazone in chemically induced mammary carcinogenesis in rats
- (2010) Bianka Bojková et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells
- (2010) Patrice E. Moss et al. EXPERIMENTAL CELL RESEARCH
- Upregulation of PPARγ in Tissue with Gastric Carcinoma
- (2010) Liping Yao et al. HYBRIDOMA
- Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines
- (2010) Karen Bräutigam et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival
- (2010) Stamatios Theocharis et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Inverse association of PPARγ agonists use and high grade glioma development
- (2010) Christian Grommes et al. JOURNAL OF NEURO-ONCOLOGY
- Cytotoxic effects of statins and thiazolidinediones on meningioma cells
- (2010) Sonja Gehring et al. JOURNAL OF NEURO-ONCOLOGY
- Of Mice and Humans: Are They the Same?--Implications in Cancer Translational Research
- (2010) M. de Jong et al. JOURNAL OF NUCLEAR MEDICINE
- Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome
- (2010) Massimo Pancione et al. PLoS One
- The role of NF-κB and PPARγ in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors
- (2010) Vivek Vaish et al. TUMOR BIOLOGY
- Peroxisome proliferator-activated receptor γ and colorectal cancer
- (2010) Yun Dai World Journal of Gastrointestinal Oncology
- Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARγ signaling pathway
- (2009) Liang-qi Cao et al. ACTA PHARMACOLOGICA SINICA
- Combined Low Doses of PPARγ and RXR Ligands Trigger an Intrinsic Apoptotic Pathway in Human Breast Cancer Cells
- (2009) Daniela Bonofiglio et al. AMERICAN JOURNAL OF PATHOLOGY
- Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats
- (2009) Kulbhushan Tikoo et al. BMC CANCER
- Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model
- (2009) C. M. Lyon et al. CARCINOGENESIS
- Pioglitazone suppresses the lipopolysaccharide-induced production of inflammatory factors in mouse macrophages by inactivating NF-κB
- (2009) Caihui Ao et al. CELL BIOLOGY INTERNATIONAL
- Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor γ
- (2009) Xiaoqi Li et al. CELL RESEARCH
- Reduced β-catenin and peroxisome proliferator–activated receptor–γ expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome
- (2009) Massimo Pancione et al. HUMAN PATHOLOGY
- In Vitro and In Vivo Anti-Melanoma Effects of Ciglitazone
- (2009) Thomas Botton et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- PPARγ and RXRγ ligands act synergistically as potent antineoplastic agentsin vitroandin vivoglioma models
- (2009) Alessio Papi et al. JOURNAL OF NEUROCHEMISTRY
- Rosiglitazone inhibits 4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor -independent signals
- (2009) X. Sun et al. MOLECULAR CANCER THERAPEUTICS
- The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells
- (2009) Kun-Huang Yan et al. MOLECULAR CARCINOGENESIS
- Enhanced effects of PPARγ ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells
- (2009) Rocchi ONCOLOGY REPORTS
- Peroxisome proliferator-activated receptor gamma in human prostate carcinoma
- (2009) Yasuhiro Nakamura et al. PATHOLOGY INTERNATIONAL
- Results of Rosiglitazone Therapy in Patients with Thyroglobulin-Positive and Radioiodine-Negative Advanced Differentiated Thyroid Cancer
- (2009) Electron Kebebew et al. THYROID
- Effects of the PPARγ agonist troglitazone on endothelial cells in vivo and in vitro: Differences between human and mouse
- (2009) Satoko Kakiuchi-Kiyota et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma
- (2009) Stefanie Meyer et al. PPAR Research
- Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells
- (2008) Hong-Nu Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3
- (2008) Gabriela Magenta et al. BMC CANCER
- Peroxisome Proliferator-Activated Receptor Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
- (2008) F. Ondrey CLINICAL CANCER RESEARCH
- Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: Association with differentiation, proliferation and clinical outcome
- (2008) E. Mylona et al. EJSO
- Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model
- (2008) Naomi Shimazaki et al. EUROPEAN JOURNAL OF CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines
- (2008) Eleonore Fröhlich et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis
- (2008) Shuji Ogino et al. GASTROENTEROLOGY
- Rosiglitazone Effect on Radioiodine Uptake in Thyroid Carcinoma Patients with High Thyroglobulin but Negative Total Body Scan: A Correlation with the Expression of Peroxisome Proliferator–Activated Receptor-Gamma
- (2008) Supatporn Tepmongkol et al. THYROID
- Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types
- (2008) Jack D. Burton et al. PPAR Research
- PPARγand MEK Interactions in Cancer
- (2008) Elke Burgermeister et al. PPAR Research
- Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model
- (2007) W. WU et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started